Fund shareholders of Rigel Pharmaceuticals Inc
ISIN US7665597024 · United States · LEI 529900KPTNUS5J8K9K66
- Fund shareholders
- 204
- Of which ETFs
- 49 155 other funds
- Value held
- ≈ 166.5M $ 166.5M $ · 255 €
- Share of capital
- 30.7 % of 18.7M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 18 | 486.7 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 6 | 208.4 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 5 | 135.2 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GESTION BOUTIQUE VIII, FI GESTION BOUTIQUE VIII / RIVER GLOBAL ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 255 € | 0.01 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| First Trust Dow Jones Select MicroCap Index Fund First Trust Exchange-Traded Fund | 0.69 % | as of Mar 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.65 % | as of Mar 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.57 % | as of Apr 30, 2026 ↗ |
| Simplify Piper Sandler US Small-Cap PLUS Income ETF Simplify Exchange Traded Funds | 0.53 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.52 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.41 % | as of Feb 28, 2026 ↗ |
| AUER GROWTH Unified Series Trust | 0.38 % | as of Feb 28, 2026 ↗ |
| MFS Blended Research Small Cap Equity Fund MFS SERIES TRUST X | 0.37 % | as of Feb 28, 2026 ↗ |
| First Trust Active Factor Small Cap ETF First Trust Exchange-Traded Fund VIII | 0.37 % | as of Feb 28, 2026 ↗ |
| SIIT SMALL CAP FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 0.34 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 203 | +1 | 5,727,622 | +17.5 % |
| 2026Q1 | 202 | +7 | 4,875,074 | +14.4 % |
| 2025Q4 | 195 | +33 | 4,261,752 | +9.2 % |
| 2025Q3 | 162 | +7 | 3,904,443 | +5.8 % |
| 2025Q2 | 155 | +29 | 3,689,178 | -10.8 % |
| 2025Q1 | 126 | +10 | 4,134,081 | +37.2 % |
| 2024Q4 | 116 | +18 | 3,012,628 | +26.9 % |
| 2024Q3 | 98 | 2,374,386 |
Institutional managers
142 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 1,768,907 | 47.8M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,280,000 | 34.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,120,238 | 30.3M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 666,426 | 18K $ | as of Mar 31, 2026 |
| LSV ASSET MANAGEMENT | 601,507 | 16.3K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 598,378 | 16.2M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 544,431 | 14.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 445,678 | 12.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 440,626 | 11.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 439,101 | 11.9M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 405,807 | 11M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 379,541 | 10.3M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 343,897 | 9.3M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 338,441 | 9.2M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 337,427 | 9.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 264,410 | 7.1M $ | as of Mar 31, 2026 |
| CM Management, LLC | 235,000 | 6.4M $ | as of Mar 31, 2026 |
| GLOBEFLEX CAPITAL L P | 217,839 | 5.9M $ | as of Mar 31, 2026 |
| Trexquant Investment LP | 216,410 | 5.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 176,850 | 4.8M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 167,342 | 4.5M $ | as of Mar 31, 2026 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 151,311 | 3.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 144,131 | 3.9M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 135,877 | 3.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 134,570 | 3.6M $ | as of Mar 31, 2026 |
Declared shareholders of Rigel Pharmaceuticals Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 6.93 % | 1,280,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Soleus Capital Master Fund, L.P. and 5 others | 5.20 % | 968,108 | as of May 6, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Rigel Pharmaceuticals Inc". https://titelia.com/en/stocks/rigel-pharmaceuticals-inc-US7665597024